Fig. 1.
Patient flow from SATT trial into present analyses. Nonadherence represents patients with tamoxifen concentrations below 40 nm.
Patient flow from SATT trial into present analyses. Nonadherence represents patients with tamoxifen concentrations below 40 nm.